1695P Phase I LITESPARK-018: Dose Escalation Study of Belzutifan in Advanced Pretreated Clear Cell Renal Cell Carcinoma (Ccrcc)
Annals of Oncology(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined